Avanir

Pharma

Eisai, GSK, Daiichi Sankyo—Fierce Pharma Asia

Eisia's lecanemab phase 3 had one patient death. China suspends GSK from volume-based procurement. Daiichi increases its Enhertu sales projection.
Angus Liu Nov 4, 2022 9:00am

Astellas, Takeda, Lilly-Innovent and more—FiercePharmaAsia

Jan 17, 2020 8:40am

Otsuka's Avanir unit plots 140 layoffs after Nuedexta settlement

Jan 10, 2020 11:35am

Otsuka, China's bidding, Aurobindo and more—FiercePharmaAsia

Sep 27, 2019 10:10am

Avanir agrees to pay $116M over Nuedexta kickbacks probe

Sep 26, 2019 3:55pm

Feds put Acadia's Nuplazid marketing under the microscope

Mar 11, 2019 11:12am